Why big pharma has abandoned antibiotics

Author: admin
Published date: 27 October 2020
Category:
Innovation
Share

What you need to know

A lack of financial incentive has meant large pharmaceutical companies have left the market

Despite the clear need for more antimicrobial agents, such drugs have not been forthcoming. Fewer new antibiotics are reaching the market; the last entirely original class of antibiotic was discovered in the late 1980s. One reason is that discovering and bringing antibiotics to market is often not profitable for pharmaceutical companies.

 

Stay Updated

Stay connected to keep up with the latest on antimicrobial resistance.

Name(Required)